title: Effects of human chorionic gonadotrophin administration on day 5 after oestrus on corpus luteum characteristics, circulating progesterone and conceptus elongation in cattle.
abstract: The aim of the present study was to test the hypothesis that elevated concentrations of progesterone (P4) resulting from the induction of an accessory corpus luteum (CL) by human chorionic gonadotrophin (hCG) administration on day 5 after oestrus would lead to advanced conceptus elongation on day 14 following embryo transfer on day 7. The oestrous cycles of cross-bred beef heifers were synchronised and animals were randomly assigned to receive either of two treatments: (1) intramuscular injection of 3000 IU hCG on day 5 after oestrus (n=14); or (2) intramuscular injection of saline on day 5 after oestrus (n=13). Ovaries were scanned daily by transrectal ultrasonography to assess CL development. Serum concentrations of P4 were determined from daily blood samples collected from the jugular vein. In vitro-produced bovine blastocysts were transferred to synchronised recipients on day 7 after oestrus (n=15 blastocysts per recipient). Heifers were killed on day 14 after oestrus and the uterus was flushed to recover the embryos. Injection of hCG on day 5 induced ovulation of the dominant follicle in all treated heifers and increased the total area of luteal tissue on the ovary, which was associated with a significant increase (P<0.001) in serum concentrations of P4 from day 7 to day 14. Positive associations were detected between circulating P4 with CL area (within-day correlations ranging from r=0.45 to r=0.67) and total area of luteal tissue (within-day correlations ranging from r=0.65 to r=0.86) Administration of hCG did not affect the proportion of day 14 conceptuses recovered. However, compared with the control group, hCG-treated heifers had increased conceptus length (3.91±1.23 vs. 5.57±1.02 mm, respectively; P=0.06), width (1.00±0.06 vs. 1.45±0.05 mm, respectively; P=0.002) and area (5.71±0.97 vs. 8.31±0.83, respectively; P=0.02). Although numerically greater, mean interferon-τ (IFNT) production in vitro did not differ significantly (P=0.54) between embryos recovered from hCG-treated and control heifers. In contrast, there was a strong positive correlation between individual embryo length (r=0.76; P<0.001) and individual embryo area (r=0.72; P<0.001) and IFNT production. In conclusion, administration of hCG on day 5 after oestrus resulted in the formation of an accessory CL and hypertrophy of the original CL, the result of which was an increase in P4 concentrations from day 7 onwards. These elevated P4 concentrations were associated with an increased conceptus area. Furthermore, conceptus size was highly correlated with IFNT secretion in vitro.
authors.affiliation: Departamento de Reproducción Animal, Instituto Nacional de Investigación y Tecnología Agraria y Alimentaria (INIA), Carretera de la Coruna, KM 5.9, 28040 Madrid, Spain.
authors.forename: D
authors.initials: D
authors.lastname: Rizos
authors.forename: S
authors.initials: S
authors.lastname: Scully
authors.forename: A K
authors.initials: AK
authors.lastname: Kelly
authors.forename: A D
authors.initials: AD
authors.lastname: Ealy
authors.forename: R
authors.initials: R
authors.lastname: Moros
authors.forename: P
authors.initials: P
authors.lastname: Duffy
authors.forename: A
authors.initials: A
authors.lastname: Al Naib
authors.forename: N
authors.initials: N
authors.lastname: Forde
authors.forename: P
authors.initials: P
authors.lastname: Lonergan
mesh_terms: D000818:Animals; D001755:Blastocyst / Q000000981:diagnostic imaging / Q000187:drug effects / Q000502:physiology; D002417:Cattle / Q000196:embryology / Q000502:physiology; D006063:Chorionic Gonadotropin / Q000008:administration & dosage / Q000494:pharmacology*; D003338:Corpus Luteum / Q000000981:diagnostic imaging / Q000187:drug effects* / Q000502:physiology; D004334:Drug Administration Schedule; D047108:Embryonic Development / Q000187:drug effects* / Q000502:physiology; D004971:Estrus / Q000187:drug effects / Q000502:physiology; D005260:Female; D005307:Fertilization in Vitro / Q000379:methods / Q000662:veterinary; D006801:Humans; D011247:Pregnancy; D011270:Pregnancy, Animal / Q000187:drug effects; D011374:Progesterone / Q000097:blood*; D013997:Time Factors; D014463:Ultrasonography
chemical_list: D006063:Chorionic Gonadotropin; D011374:Progesterone